73 companies

Madrigal Pharmaceuticals

Market Cap: US$11.9b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

MDGL

US$517.26

7D

-1.2%

1Y

93.3%

Zevra Therapeutics

Market Cap: US$592.9m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

ZVRA

US$10.03

7D

-8.9%

1Y

16.0%

Camurus

Market Cap: SEK 31.4b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

CAMX

SEK 525.50

7D

3.1%

1Y

3.8%

Syndax Pharmaceuticals

Market Cap: US$1.8b

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

SNDX

US$19.94

7D

-1.4%

1Y

102.4%

Oscotec

Market Cap: ₩1.6t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

A039200

₩42,250.00

7D

-10.5%

1Y

58.8%

Starpharma Holdings

Market Cap: AU$261.1m

A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.

SPL

AU$0.62

7D

0%

1Y

596.6%

Bonesupport Holding

Market Cap: SEK 16.9b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

BONEX

SEK 256.80

7D

5.8%

1Y

-2.7%

HansBiomed

Market Cap: ₩410.7b

Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

A042520

₩28,800.00

7D

15.7%

1Y

251.2%

Ardelyx

Market Cap: US$1.5b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARDX

US$6.11

7D

-1.9%

1Y

53.9%

AnaptysBio

Market Cap: US$1.7b

A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.

ANAB

US$59.71

7D

-5.4%

1Y

192.1%

Cutia Therapeutics

Market Cap: HK$1.5b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

2487

HK$4.16

7D

-5.0%

1Y

-51.9%

Pharma Mar

Market Cap: €1.7b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

PHM

€100.80

7D

4.7%

1Y

19.9%

Capricor Therapeutics

Market Cap: US$1.7b

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

CAPR

US$28.87

7D

0.3%

1Y

181.7%

ARS Pharmaceuticals

Market Cap: US$788.5m

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.

SPRY

US$7.94

7D

6.9%

1Y

-47.0%

Ascentage Pharma Group International

Market Cap: HK$15.3b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

6855

HK$41.64

7D

6.0%

1Y

-17.6%

Lineage Cell Therapeutics

Market Cap: US$324.1m

A clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally.

LCTX

US$1.30

7D

4.0%

1Y

86.1%

Ocumension Therapeutics

Market Cap: HK$5.1b

Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.

1477

HK$6.24

7D

-4.7%

1Y

-13.5%

Bide Pharmatech

Market Cap: CN¥4.8b

Engages in the research, development, production, and sale of pharmaceutical products in China.

688073

CN¥55.40

7D

0.3%

1Y

30.2%

Intellia Therapeutics

Market Cap: US$1.8b

Operates as a clinical-stage genome editing company focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies.

New

NTLA

US$12.60

7D

-7.8%

1Y

37.6%

Aldeyra Therapeutics

Market Cap: US$93.5m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.

ALDX

US$1.55

7D

-7.7%

1Y

-30.2%

Clinuvel Pharmaceuticals

Market Cap: AU$458.9m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

CUV

AU$9.10

7D

-3.9%

1Y

-14.6%

Imexpharm

Market Cap: ₫7.2t

Operates as a pharmaceutical company in Vietnam.

IMP

₫46,650.00

7D

-0.9%

1Y

-10.3%

AC Immune

Market Cap: US$280.7m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

ACIU

US$2.83

7D

1.4%

1Y

67.5%

CG Oncology

Market Cap: US$5.7b

A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.

CGON

US$64.25

7D

-4.0%

1Y

152.6%

BioStem Technologies

Market Cap: US$70.1m

Engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States.

BSEM

US$4.14

7D

-4.3%

1Y

-65.5%

Arcutis Biotherapeutics

Market Cap: US$2.6b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

ARQT

US$20.86

7D

-2.2%

1Y

49.2%

Bora Pharmaceuticals

Market Cap: NT$48.2b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

6472

NT$379.50

7D

7.5%

1Y

-41.5%

Oxford Biomedica

Market Cap: UK£747.3m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

OXB

UK£6.18

7D

0%

1Y

93.1%

May & Baker Nigeria

Market Cap: ₦86.3b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

MAYBAKER

₦50.00

7D

5.7%

1Y

325.5%

Devyser Diagnostics

Market Cap: SEK 1.6b

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.

DVYSR

SEK 96.50

7D

7.3%

1Y

-3.5%

Genovis AB (publ.)

Market Cap: SEK 1.4b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

GENO

SEK 20.45

7D

-1.0%

1Y

-22.4%

Kuros Biosciences

Market Cap: CHF 852.5m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

KURN

CHF 21.76

7D

5.9%

1Y

-10.9%

Belite Bio

Market Cap: US$5.4b

A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States.

BLTE

US$137.30

7D

-4.0%

1Y

125.1%

Neurocrine Biosciences

Market Cap: US$15.8b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

NBIX

US$156.70

7D

-1.1%

1Y

30.4%

Insmed

Market Cap: US$23.0b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

INSM

US$106.24

7D

-2.7%

1Y

57.3%

Vera Therapeutics

Market Cap: US$2.4b

A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases.

VERA

US$34.04

7D

-8.8%

1Y

73.3%

Page 1 of 3